Official data for the 2022/23 financial year revealed a record £10.4bn was spent on supplying drugs in England last year — up 8 per cent on the previous calendar year.
Drugs designed to treat type 2 diabetes, a common health complication of obesity, were the biggest burden. The Daily Mail
See also:
- How obesity evolved from a lack of willpower into a disease The Daily Telegraph
- Weight-loss drugs aren’t a magic bullet for Britain’s obesity crisis The Guardian
No comments:
Post a Comment